Massive Pheochromocytomatosis Treated With Cytoreductive Surgery

采用细胞减灭术治疗巨大嗜铬细胞瘤

阅读:2

Abstract

A 35-year-old woman presented in 2022 to the Carling Adrenal Center with recurrent palpitations, anxiety, and diaphoresis, 9 years after right laparoscopic adrenalectomy at a local hospital for pheochromocytoma, diagnosed during pregnancy with placental abruption. Biochemical evaluation revealed markedly elevated 24-hour urinary and plasma fractionated metanephrines. Imaging identified extensive intra-abdominal tumor implants and a solitary liver lesion, raising suspicion for pheochromocytomatosis vs metastatic disease. Genetic testing was negative for major known pathogenic variants. Cytoreductive surgery successfully resected more than 200 tumor deposits, including a 15.5 cm omental mass, without complications. Pathology confirmed pheochromocytomatosis, with the liver lesion identified as focal nodular hyperplasia. Postoperatively, symptoms resolved, biochemical markers significantly improved but remain at ∼2.5- to 3.8 times above normal range, indicating residual microscopic disease (40 months follow-up). This case highlights the feasibility of cytoreductive surgery for extensive pheochromocytomatosis and the challenging distinction between tumor seeding and metastatic pheochromocytoma, emphasizing the need for lifelong biochemical surveillance.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。